As of 2026-04-06, the Relative Valuation of Dongkook Pharmaceutical Co Ltd (086450.KQ) is 22,522.62 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 27,400.00 KRW, the upside of Dongkook Pharmaceutical Co Ltd based on Relative Valuation is -17.8%.
The range of the Relative Valuation is 19,497.01 - 26,475.39 KRW.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 13.4x | 11.7x |
| Forward P/E multiples | 10.2x - 12.4x | 11.1x |
| Fair Price | 19,497.01 - 26,475.39 | 22,522.62 |
| Upside | -28.8% - -3.4% | -17.8% |
| Date | P/E |
| 2026-03-30 | 12.72 |
| 2026-03-27 | 12.31 |
| 2026-03-26 | 11.34 |
| 2026-03-25 | 11.04 |
| 2026-03-24 | 9.99 |
| 2026-03-23 | 9.87 |
| 2026-03-20 | 10.35 |
| 2026-03-19 | 9.88 |
| 2026-03-18 | 10.10 |
| 2026-03-17 | 10.01 |
| 2026-03-16 | 9.77 |
| 2026-03-13 | 10.15 |
| 2026-03-12 | 10.19 |
| 2026-03-11 | 10.22 |
| 2026-03-10 | 10.63 |
| 2026-03-09 | 10.41 |
| 2026-03-06 | 10.95 |
| 2026-03-05 | 10.32 |
| 2026-03-04 | 9.72 |
| 2026-03-03 | 10.86 |
| 2026-02-27 | 11.26 |
| 2026-02-26 | 11.29 |
| 2026-02-25 | 11.70 |
| 2026-02-24 | 12.14 |
| 2026-02-23 | 11.34 |
| 2026-02-20 | 11.31 |
| 2026-02-19 | 11.48 |
| 2026-02-13 | 9.99 |
| 2026-02-12 | 10.02 |
| 2026-02-11 | 10.12 |
| 2026-02-10 | 10.20 |
| 2026-02-09 | 9.92 |
| 2026-02-06 | 9.63 |
| 2026-02-05 | 9.95 |
| 2026-02-04 | 10.11 |
| 2026-02-03 | 10.03 |
| 2026-02-02 | 9.88 |
| 2026-01-30 | 10.37 |
| 2026-01-29 | 10.36 |
| 2026-01-28 | 10.18 |
| 2026-01-27 | 9.93 |
| 2026-01-26 | 9.76 |
| 2026-01-23 | 9.43 |
| 2026-01-22 | 9.16 |
| 2026-01-21 | 9.16 |
| 2026-01-20 | 9.19 |
| 2026-01-19 | 9.06 |
| 2026-01-16 | 9.12 |
| 2026-01-15 | 9.15 |
| 2026-01-14 | 9.14 |